BML Investment Partners, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share (PMVP)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share
Symbol: PMVP
Shares outstanding: 53,454,545 shares
Disclosed Ownership: 5,292,000 shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Filing time: 09 Feb 2026, 14:19:24 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	9.9%	5,292,000	0	5,292,000	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member